Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
Merck
Colorcon
Express Scripts

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR BISOPROLOL FUMARATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Bisoprolol Fumarate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00702156 ↗ Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease Terminated NHS Greater Glasgow and Clyde Phase 2 2005-03-01 The principal research objectives are to demonstrate cardioselective beta-blockade using bisoprolol is not inferior to placebo with regard to pulmonary function and improves quality of life in patients with heart failure and coexistent moderate or severe chronic obstructive pulmonary disease with or without significant reversibility. Patients will be followed up for 4 months during which bisoprolol will be up-titrated to the maximum clinically tolerated dose. Health status will be assessed using a generic and two disease specific questionnaires, and pulmonary function by spirometry, body box plethysmography, and cardiopulmonary exercise testing.
NCT01741623 ↗ Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition Completed IPCA Laboratories Ltd. Phase 1 2012-08-01 This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult human subjects.
NCT01744873 ↗ Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition Completed IPCA Laboratories Ltd. Phase 1 2012-08-01 This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult human subjects.
NCT03299452 ↗ Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Unknown status Alphacait, LLC Phase 2 2017-01-01 This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Bisoprolol Fumarate

Condition Name

Condition Name for Bisoprolol Fumarate
Intervention Trials
Cardiomyopathy, Dilated 1
Chronic Obstructive Pulmonary Disease 1
Duchenne Muscular Dystrophy 1
Essential Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Bisoprolol Fumarate
Intervention Trials
Muscular Dystrophy, Duchenne 1
Lung Diseases, Obstructive 1
Muscular Dystrophies 1
Lung Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Bisoprolol Fumarate

Trials by Country

Trials by Country for Bisoprolol Fumarate
Location Trials
India 2
Russian Federation 2
China 2
United Kingdom 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Bisoprolol Fumarate

Clinical Trial Phase

Clinical Trial Phase for Bisoprolol Fumarate
Clinical Trial Phase Trials
Phase 3 1
Phase 2/Phase 3 1
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Bisoprolol Fumarate
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Bisoprolol Fumarate

Sponsor Name

Sponsor Name for Bisoprolol Fumarate
Sponsor Trials
IPCA Laboratories Ltd. 2
Laval University 1
Université de Sherbrooke 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Bisoprolol Fumarate
Sponsor Trials
Other 8
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
Mallinckrodt
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.